Provided by Tiger Trade Technology Pte. Ltd.

Capital Research Global Investors

2,935.10
+7.340.25%
Number of Gainers:42
Number of Losers:53
Number of Flat:- -
PE:- -
High:2,940.37
Open:2,927.54
Low:2,924.30
Close:2,927.54
Volume:123.47M
Turnover:21.30B
Market Cap:33.55T
Float Cap:31.88T

Loading ...

Evonik (0QDS) Gets a Hold from Deutsche Bank

TIPRANKS
·
Oct 01

Apple’s iPhone Duo needs to overcome competition in China, WSJ says

TIPRANKS
·
Oct 01

Sea CCO and GC Wang Yanjun Disposes of USD 195,968 in Common Shares

Reuters
·
Oct 01

Netflix co-CEO says company ‘not growing as fast as I want,’ Bloomberg says

TIPRANKS
·
Oct 01

Micron Falls 0.8% Pre-Market After Q4 Profit and Revenue Surge

Deep News
·
Oct 01

Why Is Google Stock Rising in Pre-Market Today and Why Is Cathie Wood Selling $1.9 Million of GOOGL?

TIPRANKS
·
Oct 01

Inside Advanced Micro Devices’ $8.2 Billion World Labs Acquisition & Its Hidden AI Synergies!

Smartkarma
·
Oct 01

Micron Earnings Suggest Strong Multiyear Narrative

Dow Jones
·
Oct 01

Broadcom to Lend up to $42 Billion to Anthropic for Infrastructure Lease Agreements

MT Newswires Live
·
Oct 01

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Oct 01

Micron Technology Price Target Maintained with a $1650.00/Share by Needham

Dow Jones
·
Oct 01

Micron, Paramount, Nike, Constellation Energy, Vicor, and More Stocks That Explain Today's Market

Dow Jones
·
Oct 01

Update: Market Chatter: Anthropic Routed Nearly Half of 2025 Sales to Customers Via Amazon, Google

MT Newswires Live
·
Oct 01

Micron Valuation Looks Too Low if Chip-Supply Tightness Continues

Dow Jones
·
Oct 01

EOG Resources, Inc. : JP Morgan Raises Target Price to $164 from $151

THOMSON REUTERS
·
Oct 01

Positive Report for NORMA Group SE (0P38) from Warburg Research

TIPRANKS
·
Oct 01

Alphabet Class A (GOOGL) Receives a Buy from KeyBanc

TIPRANKS
·
Oct 01

Teva initiated with a Buy at TD Cowen

TIPRANKS
·
Oct 01

Wall Street Analysts Are Bullish on Top Consumer Cyclical Picks

TIPRANKS
·
Oct 01

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 01